Evidence map›Paper›PMID 40921490›Full record

ArticleBMJ open diabetes research & care2025

Latent class growth mixture modeling of HbA1C trajectories identifies individuals at high risk of developing complications of type 2 diabetes mellitus in the UK Biobank.

Dale Handley, Alexandra C Gillett, Renu Bala, Jessica Tyrrell, Cathryn M Lewis

Abstract read
In one paragraph

Article in BMJ open diabetes research & care, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 4 papers.

0numbers the graph read from it
0cells of the map it votes in
4citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

4 citing papers in PubMed.

  1. Article
  2. Article
  3. Article
  4. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors.

Dale Handley *NIHR Maudsley Biomedical Research Centre, South London and Maudsley NHS Foundation Trust, London, UK dale.handley@kcl.ac.uk.ORCID http://orcid.org/0009-0008-0944-1634
Alexandra C Gillett *NIHR Maudsley Biomedical Research Centre, South London and Maudsley NHS Foundation Trust, London, UK.
Renu BalaClinical and Biomedical Science, Institute of Health and Life Sciences, University of Exeter, Exeter, UK.
Jessica TyrrellClinical and Biomedical Science, Institute of Health and Life Sciences, University of Exeter, Exeter, UK.
Cathryn M LewisNIHR Maudsley Biomedical Research Centre, South London and Maudsley NHS Foundation Trust, London, UK.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

introductionFrequent glycated hemoglobin A1c (HbA1c) monitoring is recommended in individuals with type 2 diabetes mellitus (T2D). We aimed to identify distinct, long-term HbA1c trajectories following a T2D diagnosis and investigate how these glycemic control trajectories were associated with health-related traits and T2D complications. RESEARCH DESIGN AND

methodsA cohort of 12,435 unrelated individuals of European ancestry with T2D was extracted from the UK Biobank data linked to primary care records. Latent class growth mixture modeling was applied to identify classes with similar HbA1c trajectories over the 10 years following T2D diagnosis. Associations between HbA1c class membership and sociodemographic factors, biomarkers, polygenic scores, and T2D-related outcomes, were tested using logistic regression and Cox proportional hazards models.

resultsSix HbA1c trajectory classes were identified. The largest class (76.8%) maintained low and stable HbA1c levels over time. Five additional smaller classes with distinct, but more variable, trajectories were found and were associated with younger age at T2D diagnosis, higher fasting glucose levels, higher random glucose levels, higher body mass index polygenic score and increased healthcare use before T2D diagnosis. Relative to the low and stable class, these five showed increased risks of T2D complications, including stroke (HR=1.55 (1.31-1.84)), kidney disease (HR=1.39 (1.27-1.53)), all-cause mortality (HR=1.36 (1.23-1.51)), and progression to combination therapy (HR=3.22 (3.04-3.41)) or insulin (HR=3.21 (2.89-3.55)).

conclusionIndividuals with T2D who show higher and more variable HbA1c trajectories are at increased risk of developing T2D-related complications. Early identification of patients at risk, based on factors such as age at diagnosis and previous healthcare utilization could improve patient outcomes.

Indexed as

BiomarkersDiabetes ComplicationsDiabetes Mellitus, Type 2Glycated HemoglobinAgedBiological Specimen BanksBlood GlucoseFemaleFollow-Up StudiesHumansLatent Class AnalysisMaleMiddle AgedPrognosisRisk FactorsUK BiobankBiomarkersBlood GlucoseGlycated Hemoglobinhemoglobin A1c protein, humanClassificationDepressionDiabetes Mellitus, Type 2HbA1c

Identifiers

PMID40921490
PMCPMC12421182

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.